Insulet Corp (PODD):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10102
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetic s. Omnipod system consists of a disposable self-adhesive tubeless insulin infusion device, OmniPod, and a handheld wireless device, Personal Diabetes Manager. The company also works in partnership with biotechnology and pharmaceutical companies that utilize the customized form of its Omnipod system to deliver drugs at specified intervals of time at predetermined doses. The company markets and sells its products directly and through distribution partners in North America, Asia and Europe. Insulet is headquartered in Billerica, Massachusetts, the US.

Insulet Corp (PODD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Insulet Corp, Medical Devices Deals, 2012 to YTD 2018 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Insulet Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Insulet Acquires Distribution Rights from GlaxoSmithKline 11
Debt Offering 12
Insulet Raises Private Placement of Senior Notes for USD345 Million 12
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 13
Asset Transactions 15
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 15
Insulet Corp – Key Competitors 16
Insulet Corp – Key Employees 17
Insulet Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 01, 2018: Insulet reports third quarter 2018 revenue of $151.1 million, up 24% year-over-year, and gross margin over 67%, up 700 basis points 19
Aug 02, 2018: Insulet Reports second quarter 2018 revenue of $124.3 million, up 13% year-over-year, and gross margin of 66%, up 710 basis points 20
May 03, 2018: Insulet Reports First Quarter 2018 Financial Results 21
Nov 02, 2017: Insulet Reports Third Quarter 2017 Financial Results 23
Aug 03, 2017: Insulet Reports Second Quarter 2017 Financial Results 24
May 08, 2017: Insulet Reports First Quarter 2017 Financial Results 25
Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 26
Corporate Communications 28
Sep 10, 2018: Insulet announces Shacey Petrovic, President and COO, promoted to CEO, effective January 1, 2019; Patrick Sullivan will retire as Chairman and CEO at the end of 2018 28
Aug 10, 2017: Insulet Appoints Michael R. Minogue and James C. Mullen to Board of Directors 30
May 30, 2017: Insulet Appoints Bret Christensen as Chief Commercial Officer 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Insulet Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Insulet Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Insulet Corp, Medical Devices Deals, 2012 to YTD 2018 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Insulet Acquires Distribution Rights from GlaxoSmithKline 11
Insulet Raises Private Placement of Senior Notes for USD345 Million 12
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 13
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 15
Insulet Corp, Key Competitors 16
Insulet Corp, Key Employees 17
Insulet Corp, Other Locations 18
Insulet Corp, Subsidiaries 18

List of Figures
Insulet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Insulet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Insulet Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Insulet Corp (PODD):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Statnett SF:電力:M&Aディール及び事業提携情報
    Summary Statnett SF (Statnett) transmits and distributes high voltage electricity in Norway primarily generated from its hydro-electric power plants. It operates as a system operator in the Norwegian energy system. The company is a state enterprise, established under the Act relating to state-owned …
  • Fluor Corp (FLR):石油・ガス:M&Aディール及び事業提携情報
    Summary Fluor Corp (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other services t …
  • Guernsey Electricity Ltd:企業の戦略的SWOT分析
    Guernsey Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Transnet SOC Ltd:企業の戦略的SWOT分析
    Transnet SOC Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • ORBIT Communication Systems Ltd:企業の戦略・SWOT・財務情報
    ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nerviano Medical Sciences Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Nerviano Medical Sciences Srl (NMS) is a drug development company that discovers and develops novel anticancer drugs. The company's pipeline products include anticancer compounds such as Danusertib, Encorafenib, Entrectinib, ADC Payload programs, PARP1 program, NMS-088, Brostallicin, Milcicl …
  • Leukocare AG-医療機器分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Landry’s Inc:企業の戦略・SWOT・財務情報
    Landry's Inc - Strategy, SWOT and Corporate Finance Report Summary Landry's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • James Halstead PLC (JHD):企業の財務・戦略的SWOT分析
    Summary James Halstead PLC (James Halstead) is a manufacturer and distributor of flooring products that provides commercial building equipment and flooring products. The company provides manufacturing of commercial, contract and consumer floorings. It also offers dyeing, finishing and later waterpro …
  • Spectrum Pharmaceuticals Inc (SPPI)-製薬・医療分野:企業M&A・提携分析
    Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection) …
  • The Boston Consulting Group:企業の戦略的SWOT分析
    The Boston Consulting Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Xodus Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Xodus Group Ltd (Xodus) is a provider of engineering and advisory services. The company offers services such as exploration and appraisal, development, projects, asset support, decommissioning and advisory services. Its exploration services comprise regional studies, basin modelling, acreage …
  • SNCF Mobilites Group:企業の戦略・SWOT・財務情報
    SNCF Mobilites Group - Strategy, SWOT and Corporate Finance Report Summary SNCF Mobilites Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Rose Petroleum plc (ROSE):石油・ガス:M&Aディール及び事業提携情報
    Summary Rose Petroleum plc (Rose Petroleum), formerly Vane Minerals plc is an oil and gas company. The company explores and produce oil and gas, silver, gold, copper, and uranium deposits across the US and Mexico. Its oil and gas project is located in Paradox Basin in Utah, the US, which covers over …
  • Electrical Geodesics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Electrical Geodesics Inc (EGI) is a medical device company that designs, develops and commercializes non-invasive neuro diagnostic products used to monitor and interpret brain activity. The company offers clinical products such as geodesic EEG system 400 series, spike detection software, geo …
  • CapeRay Medical (Pty) Ltd:製品パイプライン分析
    Summary CapeRay Medical (Pty) Ltd (CapeRay), formerly African Medical Imaging is a medical device company that offers imaging solutions. The company offers breast imaging devices. It offers aceso system to detect breast cancer with standard digital mammography. CapeRay’s aceso system is used for det …
  • General Motors Company:企業の戦略・SWOT・財務情報
    General Motors Company - Strategy, SWOT and Corporate Finance Report Summary General Motors Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fitbit Inc.:企業の戦略・SWOT・財務情報
    Fitbit Inc. - Strategy, SWOT and Corporate Finance Report Summary Fitbit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Seair Inc:企業の戦略的SWOT分析
    Seair Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Abeona Therapeutics Inc (ABEO):企業の財務・戦略的SWOT分析
    Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆